The DOI matches its Crossref record.
Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors
Abstract
✓ The bradykinin analog, RMP-7, was investigated for its ability to selectively increase uptake of molecular tracers in RG2 glial tumors. When infused in low doses (0.1 µg/kg/min) through the intracarotid artery ipsilateral to RG2 gliomas in rats, RMP-7 significantly increased the permeability of tumor capillaries to methotrexate and to four other tracers of varying molecular weights, compared to intracarotid infusion of vehicle alone. Tracers used to examine permeability included radiolabeled α-aminoisobutyric acid (Mr 103 D), sucrose (Mr 342 D), methotrexate (Mr 454.5 D), inulin (Mr 5000 D), and dextran (Mr 70,000 D). Permeability was expressed as the unidirectional transfer constant, K i (µl/gm/min). The permeability (K i) of tumors in the RMP-7 group compared to the vehicle control group was as follows: α-aminoisobutyric acid, 35.3 ± 9.11 versus 12.7 ± 4.56 (p < 0.001); sucrose, 16.5 ± 3.83 versus 9.28 ± 3.12 (p < 0.05); methotrexate, 26.3 ± 10.3 versus 8.98 ± 6.78 (p < 0.005); inulin, 13.5 ± 3.23 versus 6.55 ± 4.32 (p < 0.005); dextran, 15.2 ± 3.42 versus 1.47 ± 1.24 (p < 0.001). The permeability of RG2 gliomas to high-molecular-weight dextran (70,000 D) was 10.3-fold higher in the RMP-7 group than in the vehicle control group. Intracarotid infusion of RMP-7 did not significantly increase the blood volume in tumor or brain tissue. The permeability of normal brain capillaries was unaffected by intracarotid infusion of 0.1 µg/kg/min RMP-7 relative to that achieved in tumor. These data support the idea that intracarotid infusion of RMP-7 will be a useful technique for selective delivery of antitumor compounds to brain tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
van Tellingen, O., Yetkin-Arik, B., de Gooijer, M. C., Wesseling, P., Wurdinger, T., & de Vries, H. E. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.02.002 · Cited by 1,035
Inflammatory Mediators and Modulation of Blood–Brain Barrier Permeability
Abbott, N. J. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007074420772 · Cited by 803
Mechanisms of macromolecule absorption by the lungs
Patton, J. S. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00113-l · Cited by 641
Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means
KrolI, R. A., Neuwelt, E. A., & Neuwelt, E. A. (1998) · Neurosurgery · doi:10.1097/00006123-199805000-00082 · Cited by 581
Osmotic Opening of the Blood–Brain Barrier: Principles, Mechanism, and Therapeutic Applications
Rapoport, S. I. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007049806660 · Cited by 428
Metadata
- Authors
- Inamura, T., Nomura, T., Bartus, R. T., & Black, K. L.
- Venue
- Journal of Neurosurgery
- Published
- 1994-11
- Volume
- 81
- Issue
- 5
- Pages
- 752-758
- ISSN
- 0022-3085 (ISSN-L)
- OpenAlex
- W2059756213
- Cited by
- 158
- References
- 0
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors. https://app.cochat.ai/papers/10.3171/jns.1994.81.5.0752
- The paper
- Inamura, T., Nomura, T., Bartus, R. T., & Black, K. L. (1994). Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors. Journal of Neurosurgery. https://doi.org/10.3171/jns.1994.81.5.0752
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.